share_log

先施(00244)发布中期业绩 股东应占亏损2726万港元 同比扩大55.83%

The company Sinopharm (00244) released its interim results, with a shareholder's attributable loss of 27.26 million Hong Kong dollars, a year-on-year increase of 55.83%.

Zhitong Finance ·  Aug 28 22:21

Sa Sa (00244) released its mid-term business performance for 2024, with a revenue of HKD 65.05 million, a year-on-year decrease...

According to the announcement, Sa Sa (00244) released its mid-term business performance for 2024, with a revenue of HKD 65.05 million, a year-on-year decrease of 12.52%. Shareholders' loss amounted to HKD 27.26 million, a year-on-year expansion of 55.83%. The basic loss per share was HKD 0.02.

The announcement stated that in the first half of 2024, the group's department store business achieved a revenue of approximately HKD 65.3 million (compared to approximately HKD 74.3 million in the first half of 2023), a decrease of approximately 12.1% from the first half of 2023. This is mainly due to weak consumer spending and a generally low market sentiment in the retail trade in the first half of 2024.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment